Friday 30 September 2016

Ovarian Cancer Diagnostic Tests under development - Medical Devices Pipeline Assessment, 2016 Forecast & Opportunities

ResearchMoz added Latest Research Report titled " Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 " to it's Large Report database.

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Ovarian Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ovarian Cancer Diagnostic Tests pipeline products.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=825726

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Scope

- Extensive coverage of the Ovarian Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Ovarian Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

Table of Contents

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 14
2 Introduction 15
2.1 Ovarian Cancer Diagnostic Tests Overview 15
3 Products under Development 16
3.1 Ovarian Cancer Diagnostic Tests - Pipeline Products by Stage of Development 16
3.2 Ovarian Cancer Diagnostic Tests - Pipeline Products by Territory 17
3.3 Ovarian Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 18
3.4 Ovarian Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 19
3.5 Ovarian Cancer Diagnostic Tests - Ongoing Clinical Trials 20
4 Ovarian Cancer Diagnostic Tests - Pipeline Products under Development by Companies 21
4.1 Ovarian Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 21
4.2 Ovarian Cancer Diagnostic Tests - Pipeline Products by Stage of Development 25
5 Ovarian Cancer Diagnostic Tests Companies and Product Overview 29
5.1 A&G Pharmaceutical, Inc. Company Overview 29
5.2 Abnova Corporation Company Overview 31
5.3 Almac Diagnostics Limited Company Overview 33
5.4 ANGLE plc Company Overview 34
5.5 AroCell AB Company Overview 37
5.6 ArtemixRx Company Overview 38
5.7 Augusta University Company Overview 39
5.8 Aurelium BioPharma Inc. Company Overview 40
5.9 Avant Diagnostics, Inc. Company Overview 43
5.10 Axela Inc. Company Overview 44

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

No comments:

Post a Comment